# Hypofractionated Radiotherapy Plus GM-CSF, Pomalidomide and Glofitamab for Newly Diagnosed PCNS-DLBCL

> clinical trial · VERIFIED · 2026-08-06

Status: RECRUITING · Sponsor: The First Affiliated Hospital of Xiamen University · Condition: DLBCL - Diffuse Large B Cell Lymphoma

- Company: The First Affiliated Hospital of Xiamen University
- Sector: oncology
- Primary source: https://clinicaltrials.gov/study/NCT07749365

---
Source: MedFuel Intel news monitor. Verification tier: VERIFIED. Informational only, not investment advice. Corrections: media@medfuelinc.com.